Nucs AI, an AI company developing diagnostic tools and predictive imaging biomarkers for oncology and theranostics, announced a collaboration with AstraZeneca to develop AI-driven response prediction models for use in research with a PSMA-targeted radioconjugate. The collaboration focuses on metastatic prostate cancer…
Innovent Biologics, Inc. announced the companies have entered into a strategic global licensing and collaboration agreement for the research and development of 12 promising new breakthrough early-stage and de novo cancer medicines. The partnership includes licensing, co-development, and co-commercialization opportunit…
Eli Lilly and Company announced agreements to acquire three companies, Curevo Inc. (Curevo), LimmaTech Biologics AG (LimmaTech Biologics), and Vaccine Company, Inc. (Vaccine Company), that expand its research and development efforts into infectious disease. The transactions advance Lilly's strategy of investing in dif…
CordenPharma, a leading global Contract Development and Manufacturing Organization (CDMO), announces that it has entered into an agreement to acquire AmbioPharm, a U.S.-headquartered peptide API CDMO. Scaling CordenPharma's facility network AmbioPharm employs approximately 400 people across its two sites. The acquis…
Gilead Sciences, Inc. announced the successful completion of its previously announced acquisition of Tubulis GmbH, a private Germany-based, clinical-stage biotechnology company developing next-generation antibody-drug conjugates (ADCs). The acquisition brings Gilead next-generation ADC assets and a platform designed…
Elpida Therapeutics, a non-profit biotechnology company developing gene therapies for ultra-rare diseases, and Catalent, Inc., the leader in enabling the development and supply of better treatments for patients worldwide, today announced a strategic partnership to support late-phase manufacturing of Elpida’s lead prog…
Roche announced that it has entered into a definitive merger agreement to acquire PathAI, a US-based company in digital pathology and AI-powered technology for pathology laboratories and the biopharma industry. This acquisition builds on the successful partnership between Roche and PathAI, established in 2021 and scal…
Körber has signed and closed the acquisition of the remaining 30 percent stake in Körber Pharma Packaging Materials LLC, completing full ownership of the US-based packaging materials business. With this step, Körber further strengthens its long-term commitment to the North American market and sharpens its focus on s…
Piramal Pharma Solutions (PPS), a leading global Contract Development and Manufacturing Organization (CDMO) and part of Piramal Pharma Ltd., has entered a manufacturing and supply arrangement with Botanix SB Inc., a subsidiary of Botanix Pharmaceuticals Limited, a commercial dermatology company. Under this arrangemen…
Agilent Technologies Inc. announced a two-year research collaboration agreement with Singapore's Nucleic Acid Therapeutics Initiative (NATi), hosted by Agency for Science, Technology and Research (A*STAR), to accelerate research into complex oligonucleotide (oligo) candidates, a promising frontier in precision therap…
Page 8 of 37